168 related articles for article (PubMed ID: 33842599)
1. Developing and validating a novel nomogram used a competing-risks model for predicting the prognosis of primary fallopian tube carcinoma: a retrospective study based on the SEER database.
Li C; Li J; Huang Q; Feng X; Zhao F; Xu F; Han D; Lyu J
Ann Transl Med; 2021 Mar; 9(5):378. PubMed ID: 33842599
[TBL] [Abstract][Full Text] [Related]
2. Nomogram Predicting Cancer-Specific Death in Parotid Carcinoma: a Competing Risk Analysis.
Li X; Hu M; Gu W; Liu D; Mei J; Chen S
Front Oncol; 2021; 11():698870. PubMed ID: 34722245
[TBL] [Abstract][Full Text] [Related]
3. Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis.
Li C; Han D; Huang Q; Xu F; Zheng S; Li X; Zhao F; Feng X; Lyu J
BMJ Open; 2021 Jul; 11(7):e048243. PubMed ID: 34281927
[TBL] [Abstract][Full Text] [Related]
4. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
[TBL] [Abstract][Full Text] [Related]
5. Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model.
Li C; Xu F; Huang Q; Han D; Zheng S; Wu W; Zhao F; Feng X; Lyu J
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34159295
[TBL] [Abstract][Full Text] [Related]
6. A Competing Risk Nomogram for Predicting Cancer-Specific Death of Patients With Maxillary Sinus Carcinoma.
Hu M; Li X; Gu W; Mei J; Liu D; Chen S
Front Oncol; 2021; 11():698955. PubMed ID: 34504784
[TBL] [Abstract][Full Text] [Related]
7. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
8. Competing risk nomogram for predicting prognosis of patients with spinal and pelvic chordoma: A SEER-based retrospective study.
Li J; Ma C; Yuan X; Li N; Xu Y; Guo J; Liao H
Eur Spine J; 2023 Apr; 32(4):1334-1344. PubMed ID: 36805321
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World.
Zhang S; Wang Y; Zhang P; Ai L; Liu T
Front Cardiovasc Med; 2022; 9():851833. PubMed ID: 35783821
[TBL] [Abstract][Full Text] [Related]
10. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
11. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
[TBL] [Abstract][Full Text] [Related]
12. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
13. Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study.
Wang J; Yang Y; Pan J; Qiu Y; Shen S; Wang W
Jpn J Clin Oncol; 2022 Apr; 52(4):353-361. PubMed ID: 35137118
[TBL] [Abstract][Full Text] [Related]
14. Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery.
Gao L; Lyu J; Luo X; Zhang D; Jiang G; Zhang X; Gao X; Zheng S; Wang X; Shen Y
BMC Cancer; 2021 Oct; 21(1):1149. PubMed ID: 34702197
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors in Patients with Rhabdomyosarcoma Using Competing-Risks Analysis: A Study of Cases in the SEER Database.
Han D; Li C; Li X; Huang Q; Xu F; Zheng S; Wang H; Lyu J
J Oncol; 2020; 2020():2635486. PubMed ID: 33014049
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy.
Zhou X; Ning Q; Jin K; Zhang T; Ma X
BMC Cancer; 2020 Feb; 20(1):97. PubMed ID: 32019501
[TBL] [Abstract][Full Text] [Related]
17. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
[TBL] [Abstract][Full Text] [Related]
18. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
[TBL] [Abstract][Full Text] [Related]
19. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
20. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]